News stories about Spectranetics Corp (NASDAQ:SPNC) have been trending somewhat positive on Wednesday, according to Accern. Accern scores the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Spectranetics Corp earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news headlines about the medical equipment provider an impact score of 46.166879989848 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Shares of Spectranetics Corp (SPNC) remained flat at $$38.45 on Wednesday. The stock had a trading volume of 1,728,900 shares, compared to its average volume of 788,356. The company has a quick ratio of 1.43, a current ratio of 1.92 and a debt-to-equity ratio of 7.61. Spectranetics Corp has a fifty-two week low of $19.80 and a fifty-two week high of $38.55.

A number of research analysts have recently commented on SPNC shares. Stifel Nicolaus lowered shares of Spectranetics Corp from a “buy” rating to a “hold” rating and boosted their price target for the company from $34.00 to $38.50 in a research report on Wednesday, August 9th. Raymond James Financial, Inc. downgraded shares of Spectranetics Corp from an “outperform” rating to a “market perform” rating in a report on Wednesday, July 26th. Guggenheim downgraded shares of Spectranetics Corp from a “buy” rating to a “neutral” rating in a report on Friday, August 4th. Finally, Needham & Company LLC downgraded shares of Spectranetics Corp from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Ten analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $35.36.

COPYRIGHT VIOLATION NOTICE: “Spectranetics Corp (SPNC) Receiving Somewhat Positive News Coverage, Report Shows” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at

About Spectranetics Corp

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads.

Insider Buying and Selling by Quarter for Spectranetics Corp (NASDAQ:SPNC)

Receive News & Ratings for Spectranetics Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectranetics Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.